Clin2
NCT07055867Possibly a fitEnrolling by invitation

Mpox outbreak study in Equateur, DR Congo

Mpox (Monkeypox)

Part of Infections clinical trials.

This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
122 people
Ages
Any age
Study type
Observational

Who can take part

  • You or someone you trust must agree to join the study (oral consent is okay with a witness).
  • You must have a rash with deep, firm blisters or pustules that looks like mpox.
  • You must have at least one of these: fever before the rash, swollen lymph nodes (in groin, armpit, or neck), or pustules on your palms or soles.
  • A lab test (like a PCR test) must confirm you have mpox.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06984705Enrolling by invitation
Mpox outbreak study in Equateur Province, DRC

This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.

Mbandaka, Équateur Province
NCT07534267Not yet recruiting
Mpox Viral Clearance, Transmission, and Vaccine Effectiveness Study

This study in West Africa follows people with confirmed mpox (monkeypox) infection and their close contacts to understand how the virus spreads, clears from the body, and how well the mpox vaccine protects people. You may be eligible if you've recently tested positive for mpox, were exposed to someone with mpox, or live in an area offering mpox vaccination.

Conakry
NCT07093489Not yet recruiting
LC16m8 mpox vaccine study in the DRC

This study tests whether a single dose of the LC16m8 mpox vaccine is safe and works in people living in the Democratic Republic of Congo. It also monitors for side effects and tracks mpox cases to see how well the vaccine protects the community.

Kinshasa
NCT06652646Enrolling by invitation
Mpox study: biology, outcome, transmission, and spread

This study looks at how mpox affects people, how it spreads, and what happens over time. If you are being tested for mpox, you may join to help researchers learn more.

Kamituga
NCT06840197Not yet recruiting
Testing a new diagnostic for mpox with skin samples

This study is testing a new way to diagnose mpox by collecting fluid from skin blisters. It may help confirm if you have mpox more quickly and accurately.

Mbandaka, Equateur
NCT07592429Not yet recruiting
Immune Memory Study in Monkeypox Patients

This study examines how your body's immune system remembers and responds to monkeypox infection. Researchers will analyze blood samples to understand the types of immunity you develop, which may help improve future treatments and vaccines.

Hear when a new Mpox (Monkeypox) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.